Paper Details 
Original Abstract of the Article :
Organic cation transporter (OCT) 3 (SLC22A3) is a widely expressed drug transporter, handling notably metformin and platinum derivatives, as well as endogenous compounds like monoamine neurotransmitters. OCT3 has been shown to be inhibited by a few marketed tyrosine kinase inhibitors (TKIs). The pre...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/fcp.12657

データ提供:米国国立医学図書館(NLM)

Tyrosine Kinase Inhibitors: A Potential Hitch in the Drug Delivery System?

Tyrosine kinase inhibitors (TKIs) are powerful medications that target specific enzymes involved in cell signaling pathways. They're often used to treat various cancers, but this study raises an interesting question: can they interfere with the body's natural drug transport system? Researchers investigated the effects of 25 TKIs on organic cation transporter 3 (OCT3), a protein responsible for transporting various substances, including certain medications, across cell membranes. Their findings suggest that some TKIs can act as potent inhibitors of OCT3, potentially leading to drug-drug interactions and toxicity.

OCT3: A Crossroads for Drug Transport

The researchers identified 13 TKIs that significantly inhibited OCT3 activity. This raises a potential concern, as OCT3 plays a crucial role in transporting medications throughout the body. If a TKI inhibits OCT3, it could affect the absorption, distribution, and elimination of other medications, potentially leading to unwanted side effects. The study highlights the importance of considering drug-drug interactions, especially when administering TKIs.

A Navigational Challenge in the Drug Landscape

Imagine a bustling desert oasis, with camels carrying diverse goods – drugs! OCT3 acts like a guide, directing these 'camels' to their destinations. But, some TKIs can act like rogue desert winds, disrupting the flow of goods. This study reminds us that the drug landscape is intricate and complex. Understanding the interplay between various medications is crucial to ensure patient safety.

Dr.Camel's Conclusion

This study serves as a reminder that the human body is a complex network of systems. We must proceed with caution when combining medications, particularly when using TKIs. As with any new discovery, it's essential to conduct further research and ensure that these medications are used safely and effectively. The journey towards better healthcare requires constant vigilance and meticulous observation.

Date :
  1. Date Completed 2022-01-03
  2. Date Revised 2022-07-15
Further Info :

Pubmed ID

33523504

DOI: Digital Object Identifier

10.1111/fcp.12657

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.